Data Vantage: Intel Capital backs Biofourmis, Carousell-Heliconia acquire Laku6

Healthtech unicorn Biofourmis received nearly $20 million this week from Intel Capital as part of a $300 million Series D round announced in April.

The startup had earlier received $20 million from venture capital firm Openspace Ventures earlier this year as part of the same round. Intel Capital’s capital injection brings Biofourmis’s Series D equity financing to nearly $220 million.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter